| Acadia Pharmaceuticals, Inc. | (NQ: ACAD) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | Chart | Options | News | SEC Filings |
(ACAD) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
June 20, 2013
(Samurai Trader,
4/11/13)
ACAD has been on the relative strength list for months, but thanks to the scale of the chart, looks like it hasn't done much since last November. That is very misleading: this actually had a range where the op was more...(read more)
(Wall St. Cheat Sheet,
1/14/11)
See why these stocks are moving the markets after-hours and will be widely watched at tomorrow's opening bell ...
(Stock Blog Hub,
10/28/10)
This morning, Acadia Pharmaceuticals (ACAD) announced that it has entered into an agreement with Biovail Labs (BLS), a wholly owned subsidiary of Valeant Pharmaceuticals...(read more)
ACADIA Pharmaceuticals (ACAD) Company Overview
There is no analysis for ACAD yet. But you can go to Wikinvest to help create one!
